Cargando…
Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial
BACKGROUND: Fibrotic interstitial lung diseases (ILDs) are chronic and often progressive conditions resulting in substantial morbidity and mortality. Shortness of breath, a symptom often linked to oxygen desaturation on exertion, is tightly linked to worsening quality of life in these patients. Alth...
Autores principales: | Visca, Dina, Tsipouri, Vicky, Mori, Letizia, Firouzi, Ashi, Fleming, Sharon, Farquhar, Morag, Leung, Elizabeth, Maher, Toby M., Cullinan, Paul, Hopkinson, Nick, Wells, Athol U., Banya, Winston, Whitty, Jennifer A., Adamali, Huzaifa, Spencer, Lisa G., Sestini, Piersante, Renzoni, Elisabetta A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410093/ https://www.ncbi.nlm.nih.gov/pubmed/28454553 http://dx.doi.org/10.1186/s13063-017-1912-9 |
Ejemplares similares
-
Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial
por: Creamer, Andrew W., et al.
Publicado: (2019) -
Pathogenesis of idiopathic pulmonary fibrosis: review of recent findings
por: Renzoni, Elisabetta, et al.
Publicado: (2014) -
Developing a system for AMB Monitoring
por: Hancock, Thomas
Publicado: (2015) -
In-depth comparison of the metabolic and pharmacokinetic behaviour of the structurally related synthetic cannabinoids AMB-FUBINACA and AMB-CHMICA in rats
por: Fabregat-Safont, David, et al.
Publicado: (2022) -
Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial
por: Saunders, Peter, et al.
Publicado: (2017)